Cite
MLA Citation
Robert Dean et al.. “P1–342: Effects of solanezumab versus placebo administration on biomarkers in people with mild‐to‐moderate Alzheimer's disease: Results from two phase III clinical trials.” Alzheimer's & dementia, vol. 9, n.d., p. P283. http://access.bl.uk/ark:/81055/vdc_100103414498.0x00001a